WELL Health Achieves $1 Billion Annualized Revenue Run-Rate Ahead of Plan with Best Ever Quarterly EBITDA and Free Cashflow Results for Q3-2024 and Raises Annual Revenue Guidance
Portfolio Pulse from
WELL Health Technologies achieved a $1 billion annualized revenue run-rate ahead of schedule, with record revenue and EBITDA in Q3-2024. The company reported a 27% revenue increase and a 16% rise in adjusted EBITDA compared to Q3-2023, driven by strong organic growth.
November 07, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
WELL Health Technologies reported a $1 billion annualized revenue run-rate and record Q3-2024 results, with a 27% revenue increase and 16% EBITDA growth, driven by organic growth.
The significant revenue and EBITDA growth, along with achieving a $1 billion revenue run-rate ahead of schedule, indicates strong financial performance and positive market sentiment, likely boosting WHTCF's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100